Genomic Health Launches “Pass It On… Until Every Woman Knows,” To Educate People About Personalized Breast Cancer Treatment And Oncotype DX
Genomic Health, Inc. (NASDAQ: GHDX) announced the launch of an online campaign, Pass It On… Until Every Woman Knows, to educate people about personalized breast cancer treatment and the Oncotype DX® breast cancer test. The campaign uses online sharing tools and social networks to spread the information not only to patients, but also to the ...